Seminar with Jacob S. Sherkow

Law in Life Science Talk- Why the innovation of new treatments in biology is threatened by legal hurdles

Abstract

The future introduction of new treatments based on techniques such as genome editing, cell therapy, and antisense oligonucleotides might be delayed or not realized due to the unequal legal landscapes and cross-border differences. Countries that favor innovation and provide the best local policy preferences, such as market incentives, regulatory approvals, and research funding, likely will have a competitive edge. But patients will lose in the end if the negative impact of cross-border differences are not tackled.

This Law in Life Science Talk will compare the regulatory and IP landscape for one form of advanced biotechnology, N-of-1 antisense oligonucleotides (ASOs) and explore how cross-border differences are likely to affect innovation in the area, and what we should do about it.

Agenda

Registration 

Please register no later than the 4 May 2023 at 08:00 using this registration form

Bio

Jacob S. Sherkow is Professor of Law at the College of Law, Professor of Medicine at the Carle Illinois College of Medicine, and Affiliate of the Carl R. Woese Institute for Genomic Biology at the University of Illinois. Prof. Sherkow’s research focuses on the legal and ethical implications of advanced biotechnologies, especially as related to intellectual property. He is a leading expert on IP protection for genome-editing technologies, including CRISPR. He is the author of over 60 articles published in both scientific journals and traditional law reviews, including Science, Nature, the Yale Law Journal, and the Stanford Law Review. Since 2018, Sherkow has also been a Permanent Visiting Professor at the Center for Advanced Studies in Biomedical Innovation Law (“CeBIL”) at the University of Copenhagen Faculty of Law. Sherkow’s work has been recognized by both the scientific and legal communities. In 2018, he was appointed to the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar, and just completed service as an Academic Advisor to the Academies’ Committee on Emerging Science, Technology, and Innovation. Sherkow graduated cum laude from the University of Michigan Law School, where he was an editor of the Michigan Law Review. He holds an M.A. in biotechnology from Columbia University and a B.Sc. from McGill University. In addition to his legal training, Sherkow has several years of experience as a research scientist in molecular biology.